PRKCA regulates the transport activity of Rlip in lung cancer, and Rlip is an important effector of activities of PRKCA, which promote the survival, growth, and drug-resistance of cancer cells in vitro as well as phorbol ester-promoted carcinogenesis in vivo [43,44]. Here, PRKCA is linked to lung cancer.